These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4900638)

  • 1. [Experimental study of the antileukemic effect of Endoxan in combination with bone marrow cell and spleen cell transplantation].
    Bergol'ts VM; Sukhin GM
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):36-9. PubMed ID: 4900638
    [No Abstract]   [Full Text] [Related]  

  • 2. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful therapy of viral leukemia by transplantation of histocompatibly unmatched marrow.
    Meredith RF; Okunewick JP; Kuhnert PM; Brozovich BJ; Weaver EV
    Exp Hematol; 1978 Mar; 6(3):273-82. PubMed ID: 25780
    [No Abstract]   [Full Text] [Related]  

  • 4. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract]   [Full Text] [Related]  

  • 5. [Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV; Ageĭchik VM
    Eksp Onkol; 1988; 10(5):57-61. PubMed ID: 3208692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of piperazinedione (NSC 135785) plus irradiation on endogenous CFU-S, intestinal crypts, and as a possible ablative protocol for marrow transplantation as evaluated in Rauscher leukemic mice.
    Meredith RF; Okunewick JP; Kovacs CJ; Evans MJ; Dicke KA
    Radiat Res; 1982 Mar; 89(3):559-74. PubMed ID: 7038749
    [No Abstract]   [Full Text] [Related]  

  • 8. An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice.
    Glynn JP; Halpern BL; Fefer A
    Cancer Res; 1969 Mar; 29(3):515-20. PubMed ID: 4180092
    [No Abstract]   [Full Text] [Related]  

  • 9. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic effect of interleukin-7-transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation.
    Li AL; Li C; Feng YG; Yuan GH; Wang GM; Hao J; Gao X; Xie SS
    Transplant Proc; 2005 Jun; 37(5):2297-9. PubMed ID: 15964403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on immunotherapy with dendritic cell in leukemic mice model].
    Li XX; Chen XL; Ma DX; Liu CS; He XP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):73-7. PubMed ID: 16732955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Moloney virus-induced leukemia with cyclophosphamide and specifically sensitized allogeneic cells.
    Glynn JP; Kende M
    Cancer Res; 1971 Oct; 31(10):1383-8. PubMed ID: 5095130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of experimental mixed bone marrow transplantation].
    Luo H; Yang P; He F
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):418-21. PubMed ID: 11189509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow transplantation after administration of large doses of a radioactive solution of yttrium silicate with Y90 in experimental leukemia].
    Shkarenkov AA; Reshchikov VP; Vinogorova GF
    Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):38-43. PubMed ID: 4312154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.